Moilin Pharmaceuticals Llp - Company Profile

It is a business services limited liability partnership based in Pune City, Maharashtra, India, established in 2023.
2023 Pune City, Maharashtra, India Active
Last Updated:
Access Report
About Moilin Pharmaceuticals Llp

Moilin Pharmaceuticals Llp, a active limited liability partnership, was established on 16 October 2023 in Pune City, Maharashtra, India. Engaging in commission trade within the business services sector, it holds LLPIN: ACD-4338. Registered under ROC Roc Pune. It has total obligation of contribution of ₹15.00 K .

Its leadership includes Swati Parmanand Chavan (Designated Partner), Priya Kaustubh Rao (Designated Partner), Jyoti Santosh Kotgire (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at Sr No 241/2/1, J P Nagar,, Bh-Garden, Lohegaon, Pune City, Maharashtra, 411032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ACD-4338

  • Incorporation Date

    16 October 2023

  • Total Obligation of Contribution

    ₹15.00 K

  • ROC Code

    Roc Pune

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 15.00 K
  • Company Age 2 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Moilin Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Moilin Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Moilin Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Swati Parmanand Chavan Designated Partner 16 Oct 2023 Current
Priya Kaustubh Rao Designated Partner 16 Oct 2023 Current
Jyoti Santosh Kotgire Designated Partner 16 Oct 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Moilin Pharmaceuticals Llp.

Enhance accessibility to Moilin Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Moilin Pharmaceuticals Llp revenue growth over time
Moilin Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Moilin Pharmaceuticals Llp?

Unlock access to Moilin Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Moilin Pharmaceuticals Llp?

Unlock and access historical data on people associated with Moilin Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Moilin Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Moilin Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Moilin Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Moilin Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Moilin Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.

  • Director Appointment

    Progress on Swati Parmanand Chavan was appointed as a Designated Partner was appointed as a Designated Partner on 16 Oct 2023 & has been associated with this company since 2 years 3 months . was documented.

  • Director Appointment

    Priya Kaustubh Rao was appointed as a Designated Partner was appointed as a Designated Partner on 16 Oct 2023 & has been associated with this company since 2 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Jyoti Santosh Kotgire was appointed as a Designated Partner was appointed as a Designated Partner on 16 Oct 2023 & has been associated with this company since 2 years 3 months . was documented.

  • LLP Incorporation

    Progress on Moilin Pharmaceuticals Llp was registered on 16 Oct 2023 with Roc Pune & aged 2 years 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Moilin Pharmaceuticals Llp?

The LLPIN of Moilin Pharmaceuticals Llp is ACD-4338.

Where is Moilin Pharmaceuticals Llp headquartered?

Moilin Pharmaceuticals Llp is headquartered at Sr No 241/2/1, J P Nagar,, Bh-Garden, Lohegaon, Pune City, Maharashtra, 411032.

When was Moilin Pharmaceuticals Llp incorporated?

Moilin Pharmaceuticals Llp was incorporated on 16 October 2023.

Who are the current directors of Moilin Pharmaceuticals Llp?

The current directors of Moilin Pharmaceuticals Llp are

What is the primary industry of Moilin Pharmaceuticals Llp?

The primary industry of Moilin Pharmaceuticals Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available